East Sydney Doctors

Condition(s): Blood, Healthy Volunteers, Inflammatory and Immune System, Mental Health, Musculoskeletal, Other, Renal and Urogenital, Reproductive Health and Childbirth, Skin

ADDRESS: 102 Burton Street, Darlinghurst Sydney, NSW 2010, Australia
POSTAL ADDRESS: 102 Burton Street Darlinghurst
PHONE: 02 9332 2531
WEBSITE: Visit Website

Name: Dr. David Baker
Role:  Investigator
Phone: 02 9332 2531
Email: trials@eastsydneydoctors.com.au

Name: Safaa Cabot
Role: Study Coordinator
Phone: 02 9322 2531
Email: scabot@eastsydneydoctors.com.au

Name: Roshanak Mousavi
Role: Study Coordinator
Phone: 02 9332 2531
Email: rmousavi@eastsydneydoctors.com.au

Name: Anandra Guimaraes
Role: Study Coordinator
Phone: 02 9332 2531
Email: aguimaraes@eastsydneydoctors.com.au

Monday:

Tuesday:

Wednesday:

Thursday:

Friday:

Saturday:

Sunday:

COVID INFO

East Sydney Doctors Clinical Trials team each have a number of years experience in working in clinical trials.  Each member brings experience from the pharmaceutical and health care industry. 

Their combined therapeutic areas of experience includes Diabetes, Sexual Health, Neurology, Reproductive health, Chronic Pain management, Medicinal Cannabis and Dermatology.

CURRENT CLINICAL TRIALS

No active clinical trials

JOBS (CURRENT OPEN POSITIONS)

No current jobs

SITE EXPERIENCE

Protocol title: Expanded PrEP Implementation in Communities in NSW (EPIC-NSW)
Registry: ClinicalTrials.gov
Registry #: NCT02870790
Link to registry: See Registry

Protocol title: Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)
Registry: Australian New Zealand Clinical Trials Registry (ANZCTR)
Registry #: NCT01345630
Link to registry: See Registry

Protocol title: Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults
Registry: ClinicalTrials.gov
Registry #: NCT02386098
Link to registry: See Registry

Protocol title: Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Registry: ClinicalTrials.gov
Registry #: NCT01106586
Link to registry: See Registry

Protocol title: Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Registry: ClinicalTrials.gov
Registry #: NCT01309243
Link to registry: See Registry

Protocol title: A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Registry: ClinicalTrials.gov
Registry #: NCT01457768
Link to registry: See Registry

Protocol title: Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Registry: ClinicalTrials.gov
Registry #: NCT01780506
Link to registry: See Registry

Protocol title: Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Registry: ClinicalTrials.gov
Registry #: NCT01797445
Link to registry: See Registry

Protocol title: Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
Registry: ClinicalTrials.gov
Registry #: NCT01815736
Link to registry: See Registry

Protocol title: A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
Registry: ClinicalTrials.gov
Registry #: NCT01783678
Link to registry: See Registry

Protocol title: A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)
Registry: ClinicalTrials.gov
Registry #: NCT01632345
Link to registry: See Registry

Protocol title: Gilead Sustained Virologic Response (SVR) Registry
Registry: ClinicalTrials.gov
Registry #: NCT01457755
Link to registry: See Registry

Protocol title: Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
Registry: ClinicalTrials.gov
Registry #: NCT02422797
Link to registry: See Registry

Protocol title: Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial
Registry: ClinicalTrials.gov
Registry #: NCT01177059
Link to registry: See Registry

Protocol title: Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed
Registry: ClinicalTrials.gov
Registry #: NCT02603120
Link to registry: See Registry

Protocol title: Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
Registry: ClinicalTrials.gov
Registry #: NCT02603107
Link to registry: See Registry

Protocol title: Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Registry: ClinicalTrials.gov
Registry #: NCT03239223
Link to registry: See Registry

Protocol title: Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia
Registry: ClinicalTrials.gov
Registry #: NCT02833844
Link to registry: See Registry

Protocol title: Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
Registry: ClinicalTrials.gov
Registry #: NCT04139915
Link to registry: See Registry

Protocol title: A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Registry: ClinicalTrials.gov
Registry #: NCT03034915
Link to registry: See Registry

Protocol title: Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
Registry: ClinicalTrials.gov
Registry #: NCT03299049
Link to registry: See Registry

Protocol title: Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients (SMART-C)
Registry: ClinicalTrials.gov
Registry #: NCT03117569
Link to registry: See Registry

Protocol title: A Study Assessing the Efficacy and Safety of CBP-201
Registry: ClinicalTrials.gov
Registry #: NCT04444752
Link to registry: See Registry

Protocol title: A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed (SOLAR)
Registry: ClinicalTrials.gov
Registry #: NCT04542070
Link to registry: See Registry

Want access to more Site details?

Sponsors and CROs looking to choose Sites for their next clinical trial are encouraged to sign up to AustralianClinicalTrials.com. In doing so, you will get free access to any and all Site Selection Packages, ready for you to download. Curated by Sites themselves, all the information you need to know for selection is presented in an easy to read format, saving you time and money. Create an account, and become a part of the fastest growing clinical trials community today!